Short-term mortality and death causes after TACE in patients with primary liver cancer
10.3969/j.issn.1001-5256.2022.11.014
- VernacularTitle:原发性肝癌经肝动脉化疗栓塞术后短期病死率及死因分析
- Author:
Zhao LIU
1
;
Zhi LI
1
,
2
;
Kailun YANG
1
;
Siyin LI
1
;
Xiaoli ZHU
1
;
Caifang NI
1
Author Information
1. Department of Interventional Radiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China
2. Department of Interventional Radiology, Kizilsu People's Hospital of Kirgiz Autonomous Prefecture, Kizilsu Kirgiz Autonomous Prefecture, Xinjiang 845355, China
- Publication Type:Original Articles_Liver Neoplasms
- Keywords:
Liver Neoplasms;
Chemoembolization, Therapeutic;
Cause of Death;
Liver Failure
- From:
Journal of Clinical Hepatology
2022;38(11):2510-2513
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the short-term mortality of transcatheter arterial chemoembolization (TACE) in patients with primary liver cancer, and explore the possible causes of death and countermeasures. Methods All patients who underwent TACE at the Department of Interventional Radiology, First Affiliated Hospital of Soochow University from January 2015 to December 2020 were studied, but those with metastatic liver cancer or receiving combined treatment were excluded. The clinical and imaging data of all patients were collected before and 30 days after TACE, and the clinical characteristics of the patients with short-term postoperative death were analyzed. Death within 30 days after TACE was defined as short-term death. Results A total of 1466 TACE in 741 patients with primary liver cancer were included. Ten patients (10/741, 1.35%) died within 30 days after TACE, with a mortality rate of 0.68% for all TACE. The mortality rate of d-TACE and c-TACE was 1.62% (3/185) and 0.55 % (7/1281), respectively. The mortality rates of patients at China Liver Cancer Staging Ⅰ, Ⅱ, and Ⅲ stages were 0.45% (2/448), 0.33% (2/599), and 1.43% (6/419), respectively. The mean diameter of the largest lesion in death cases was 10.1±0.8 cm. The possible causes of death were liver failure (4 cases), rupture bleeding (3 cases), myelotoxicity (1 case), pulmonary embolism (1 case), and heart failure (1 case). Conclusion The mortality rate after TACE in patients with primary liver cancer is low, with occasional short-term postoperative deaths. The death cases are characterized by a large tumor volume, and the most common causes of short-term death are liver failure and rupture bleeding.
